DEGRADATOR: A Gaming Expedition Into Targeted Protein Degradation Therapies
Natalia A. Szulc,
No information about this author
Anna Olchowik,
No information about this author
Patrycja Jaszczak
No information about this author
et al.
Journal of Chemical Education,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 7, 2025
In
an
era
of
rapid
scientific
advancement,
the
need
for
engaging
educational
tools
is
critical.
DEGRADATOR,
a
2D
computer
game,
bridges
this
gap
by
immersing
players
in
ubiquitin-proteasome
system,
key
pathway
cellular
protein
degradation.
Designed
aged
12
and
above,
DEGRADATOR
introduces
molecular
mechanics
targeted
degradation,
including
PROTAC
drugs.
Through
10
levels
gameplay
combined
with
quizzes,
it
represents
first-ever
resource
its
kind
to
make
advanced
topic
accessible
amusing.
The
game
was
evaluated
97
high
school
students
(age
15–19)
during
biology
classes.
Over
75%
completed
under
30
min,
63%
rated
highly
(4
or
5
out
5)
ability
enhance
their
understanding
59%
scored
more
points
on
final
test,
indicating
substantial
knowledge
retention.
Teachers
highlighted
game's
potential
deepening
students'
comprehension
recommended
accompanying
materials
maximize
impact.
By
blending
entertainment
education,
demystifies
complex
processes,
serving
as
tool
popularizing
science
addressing
misconceptions
surrounding
new
therapeutic
technologies.
Freely
available
at
https://degradator-game.com,
complemented
teacher
resources
multimedia
materials,
ensuring
broad
applicability.
This
innovative
platform
not
only
supports
classroom
learning
but
also
fosters
curiosity
beyond
traditional
academic
settings.
Language: Английский
E3 ubiquitin ligase CHIP facilitates cAMP and cGMP signalling cross-talk by polyubiquitinating PDE9A
The EMBO Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 13, 2025
Abstract
The
carboxyl
terminus
of
Hsc70-interacting
protein
(CHIP)
is
pivotal
for
managing
misfolded
and
aggregated
proteins
via
chaperone
networks
degradation
pathways.
In
a
preclinical
rodent
model
CHIP-related
ataxia,
we
observed
that
CHIP
mutations
lead
to
increased
levels
phosphodiesterase
9A
(PDE9A),
whose
role
in
this
context
remains
poorly
understood.
Here,
investigated
the
molecular
mechanisms
underlying
PDE9A
ataxia
demonstrated
binds
PDE9A,
facilitating
its
polyubiquitination
autophagic
degradation.
Conversely,
dysfunctional
disrupts
process,
resulting
accumulation,
cGMP
hydrolysis,
impaired
PKG
phosphorylation
at
serine
19.
This
cascade
further
amplifies
ultimately
disrupting
mitophagy
triggering
neuronal
apoptosis.
Elevated
PKA
inhibit
degradation,
exacerbating
dysfunction.
Notably,
pharmacological
inhibition
Bay
73-6691
or
virus-mediated
expression
restored
balance
cGMP/cAMP
signalling.
These
interventions
protect
against
cerebellar
neuropathologies,
particularly
Purkinje
neuron
Thus,
upregulation
considerably
exacerbates
associated
with
mutations,
targeting
interaction
between
an
innovative
therapeutic
strategy
ataxia.
Language: Английский
Primary disorders of polyubiquitination: Dual roles in autoinflammation and immunodeficiency
The Journal of Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
222(5)
Published: April 15, 2025
The
last
decades
have
brought
a
rapid
expansion
of
the
number
primary
disorders
related
to
polyubiquitination
pathways
in
humans.
Most
these
manifest
with
two
seemingly
contradictory
clinical
phenotypes:
autoinflammation,
immunodeficiency,
or
both.
We
provide
an
overview
molecular
pathogenesis
disorders,
and
their
role
inflammation
infection.
By
focusing
on
data
from
human
genetic
diseases,
we
explore
complexities
corresponding
phenotypes
deficiencies.
offer
road
map
for
discovery
new
etiologies.
considering
triggers
that
induce
inflammation,
propose
autoinflammation
immunodeficiency
as
continuous
phenotypes.
Language: Английский
PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response
The American Journal of Human Genetics,
Journal Year:
2024,
Volume and Issue:
111(7), P. 1352 - 1369
Published: June 12, 2024
Language: Английский
Exploring the origins of neurodevelopmental proteasomopathies associated with cardiac malformations: are neural crest cells central to certain pathological mechanisms?
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: July 12, 2024
Neurodevelopmental
proteasomopathies
constitute
a
recently
defined
class
of
rare
Mendelian
disorders,
arising
from
genomic
alterations
in
proteasome-related
genes.
These
result
the
dysfunction
proteasomes,
which
are
multi-subunit
protein
complexes
essential
for
maintaining
cellular
homeostasis.
The
clinical
phenotype
these
diseases
manifests
as
syndromic
association
involving
impaired
neural
development
and
multisystem
abnormalities,
notably
craniofacial
anomalies
malformations
cardiac
outflow
tract
(OFT).
observations
suggest
that
proteasome
loss-of-function
variants
primarily
affect
specific
embryonic
cell
types
serve
origins
both
structures
conotruncal
portion
heart.
In
this
hypothesis
article,
we
propose
crest
cells
(NCCs),
highly
multipotent
population,
generates
skeleton,
mesenchyme
well
OFT
heart,
addition
to
many
other
derivatives,
would
exhibit
distinctive
vulnerability
homeostasis
perturbations.
Herein,
introduce
diverse
compensatory
pathways
activated
response
disruption
explore
their
potential
implications
NCC
physiology.
Altogether,
paper
advocates
investigating
biology
within
NCCs
early
cranial
offering
rationale
future
exploration
laying
initial
groundwork
therapeutic
considerations.
Language: Английский